nodes	percent_of_prediction	percent_of_DWPC	metapath
Yohimbine—CYP2D6—Lomustine—hematologic cancer	0.0542	0.0738	CbGbCtD
Yohimbine—CYP2D6—Idarubicin—hematologic cancer	0.0483	0.0658	CbGbCtD
Yohimbine—CYP2D6—Hydroxyurea—hematologic cancer	0.0411	0.0559	CbGbCtD
Yohimbine—CYP3A4—Bexarotene—hematologic cancer	0.0371	0.0505	CbGbCtD
Yohimbine—CYP2D6—Bortezomib—hematologic cancer	0.0358	0.0487	CbGbCtD
Yohimbine—CYP3A4—Lomustine—hematologic cancer	0.0345	0.0469	CbGbCtD
Yohimbine—CYP3A4—Busulfan—hematologic cancer	0.0345	0.0469	CbGbCtD
Yohimbine—CYP3A4—Thiotepa—hematologic cancer	0.0307	0.0418	CbGbCtD
Yohimbine—CYP2D6—Imatinib—hematologic cancer	0.0262	0.0357	CbGbCtD
Yohimbine—CYP3A4—Methoxsalen—hematologic cancer	0.0239	0.0325	CbGbCtD
Yohimbine—CYP2D6—Nilotinib—hematologic cancer	0.0238	0.0324	CbGbCtD
Yohimbine—CYP2D6—Vinorelbine—hematologic cancer	0.0236	0.0321	CbGbCtD
Yohimbine—CYP3A4—Bortezomib—hematologic cancer	0.0227	0.0309	CbGbCtD
Yohimbine—CYP3A4—Daunorubicin—hematologic cancer	0.0217	0.0296	CbGbCtD
Yohimbine—CYP3A4—Cytarabine—hematologic cancer	0.0192	0.0261	CbGbCtD
Yohimbine—CYP3A4—Teniposide—hematologic cancer	0.0189	0.0257	CbGbCtD
Yohimbine—CYP3A4—Ifosfamide—hematologic cancer	0.0174	0.0237	CbGbCtD
Yohimbine—CYP3A4—Imatinib—hematologic cancer	0.0167	0.0227	CbGbCtD
Yohimbine—CYP3A4—Ruxolitinib—hematologic cancer	0.0157	0.0213	CbGbCtD
Yohimbine—CYP3A4—Nilotinib—hematologic cancer	0.0151	0.0206	CbGbCtD
Yohimbine—CYP3A4—Vinorelbine—hematologic cancer	0.015	0.0204	CbGbCtD
Yohimbine—CYP2D6—Vinblastine—hematologic cancer	0.0145	0.0198	CbGbCtD
Yohimbine—CYP3A4—Triamcinolone—hematologic cancer	0.0137	0.0187	CbGbCtD
Yohimbine—CYP3A4—Dasatinib—hematologic cancer	0.0134	0.0182	CbGbCtD
Yohimbine—CYP3A4—Mitoxantrone—hematologic cancer	0.0132	0.018	CbGbCtD
Yohimbine—CYP3A4—Betamethasone—hematologic cancer	0.0118	0.016	CbGbCtD
Yohimbine—CYP3A4—Prednisolone—hematologic cancer	0.0116	0.0158	CbGbCtD
Yohimbine—CYP3A4—Prednisone—hematologic cancer	0.011	0.0149	CbGbCtD
Yohimbine—CYP2D6—Dexamethasone—hematologic cancer	0.0108	0.0147	CbGbCtD
Yohimbine—CYP3A4—Irinotecan—hematologic cancer	0.0104	0.0142	CbGbCtD
Yohimbine—CYP3A4—Vinblastine—hematologic cancer	0.00925	0.0126	CbGbCtD
Yohimbine—CYP3A4—Vincristine—hematologic cancer	0.00909	0.0124	CbGbCtD
Yohimbine—CYP2D6—Doxorubicin—hematologic cancer	0.00894	0.0122	CbGbCtD
Yohimbine—CYP3A4—Etoposide—hematologic cancer	0.00833	0.0113	CbGbCtD
Yohimbine—CYP3A4—Dexamethasone—hematologic cancer	0.00685	0.00933	CbGbCtD
Yohimbine—CYP3A4—Doxorubicin—hematologic cancer	0.00568	0.00774	CbGbCtD
Yohimbine—Reserpine—SLC22A1—hematologic cancer	0.00312	0.775	CrCbGaD
Yohimbine—Reserpine—ABCB1—hematologic cancer	0.000908	0.225	CrCbGaD
Yohimbine—ADRA1B—Signaling Pathways—CASP3—hematologic cancer	6.4e-06	2.45e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MAPK8—hematologic cancer	6.39e-06	2.45e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IL2—hematologic cancer	6.39e-06	2.44e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—AKT1—hematologic cancer	6.38e-06	2.44e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—KRAS—hematologic cancer	6.36e-06	2.43e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—IL6—hematologic cancer	6.35e-06	2.43e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CYCS—hematologic cancer	6.35e-06	2.43e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CCND1—hematologic cancer	6.33e-06	2.42e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CDKN1A—hematologic cancer	6.32e-06	2.42e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—JUN—hematologic cancer	6.31e-06	2.42e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—PTEN—hematologic cancer	6.31e-06	2.41e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MTOR—hematologic cancer	6.31e-06	2.41e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PIK3CB—hematologic cancer	6.31e-06	2.41e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	6.3e-06	2.41e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—FGF2—hematologic cancer	6.3e-06	2.41e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CDKN1A—hematologic cancer	6.29e-06	2.41e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—PTEN—hematologic cancer	6.28e-06	2.4e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—EP300—hematologic cancer	6.23e-06	2.39e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CCND1—hematologic cancer	6.23e-06	2.38e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PIK3R1—hematologic cancer	6.22e-06	2.38e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—JUN—hematologic cancer	6.21e-06	2.38e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—MAPK3—hematologic cancer	6.19e-06	2.37e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—MAPK3—hematologic cancer	6.19e-06	2.37e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MAPK8—hematologic cancer	6.17e-06	2.36e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—AKT1—hematologic cancer	6.16e-06	2.36e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MAPK8—hematologic cancer	6.14e-06	2.35e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—AKT1—hematologic cancer	6.12e-06	2.34e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—HRAS—hematologic cancer	6.12e-06	2.34e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CDKN1A—hematologic cancer	6.12e-06	2.34e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—PTEN—hematologic cancer	6.11e-06	2.34e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—SRC—hematologic cancer	6.06e-06	2.32e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—JAK2—hematologic cancer	6.04e-06	2.31e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—HRAS—hematologic cancer	6.02e-06	2.3e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CDKN1A—hematologic cancer	6.02e-06	2.3e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—EP300—hematologic cancer	6.02e-06	2.3e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—MYC—hematologic cancer	6.02e-06	2.3e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—MYC—hematologic cancer	6.02e-06	2.3e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	6.02e-06	2.3e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—PTEN—hematologic cancer	6.01e-06	2.3e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—TGFB1—hematologic cancer	6e-06	2.3e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—TGFB1—hematologic cancer	6e-06	2.3e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—EP300—hematologic cancer	5.99e-06	2.29e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—KRAS—hematologic cancer	5.98e-06	2.29e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MAPK8—hematologic cancer	5.97e-06	2.29e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—PIK3CA—hematologic cancer	5.97e-06	2.28e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—AKT1—hematologic cancer	5.96e-06	2.28e-05	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	5.95e-06	2.28e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—PTEN—hematologic cancer	5.93e-06	2.27e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—PIK3CA—hematologic cancer	5.92e-06	2.27e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CDKN1B—hematologic cancer	5.92e-06	2.27e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—VEGFA—hematologic cancer	5.9e-06	2.26e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MDM2—hematologic cancer	5.9e-06	2.26e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CASP3—hematologic cancer	5.9e-06	2.26e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IL2—hematologic cancer	5.89e-06	2.25e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MAPK8—hematologic cancer	5.88e-06	2.25e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—AKT1—hematologic cancer	5.86e-06	2.24e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—IL6—hematologic cancer	5.86e-06	2.24e-05	CbGpPWpGaD
Yohimbine—HTR2A—GPCR downstream signaling—AKT1—hematologic cancer	5.86e-06	2.24e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—SRC—hematologic cancer	5.85e-06	2.24e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—STAT3—hematologic cancer	5.85e-06	2.24e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—PIK3CA—hematologic cancer	5.84e-06	2.24e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	5.84e-06	2.23e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—NRAS—hematologic cancer	5.83e-06	2.23e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—EP300—hematologic cancer	5.82e-06	2.23e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—SRC—hematologic cancer	5.82e-06	2.23e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CASP3—hematologic cancer	5.8e-06	2.22e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IL2—hematologic cancer	5.79e-06	2.22e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—TP53—hematologic cancer	5.77e-06	2.21e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—IL6—hematologic cancer	5.76e-06	2.21e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CCND1—hematologic cancer	5.74e-06	2.2e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MTOR—hematologic cancer	5.74e-06	2.2e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PIK3CB—hematologic cancer	5.74e-06	2.2e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—EP300—hematologic cancer	5.73e-06	2.19e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—JUN—hematologic cancer	5.73e-06	2.19e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	5.7e-06	2.18e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—VEGFA—hematologic cancer	5.67e-06	2.17e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—SRC—hematologic cancer	5.66e-06	2.17e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—EP300—hematologic cancer	5.66e-06	2.16e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—TP53—hematologic cancer	5.65e-06	2.16e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CCND1—hematologic cancer	5.65e-06	2.16e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—STAT3—hematologic cancer	5.64e-06	2.16e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—JUN—hematologic cancer	5.64e-06	2.16e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—NRAS—hematologic cancer	5.63e-06	2.15e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—STAT3—hematologic cancer	5.61e-06	2.15e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—NRAS—hematologic cancer	5.6e-06	2.14e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—GSTP1—hematologic cancer	5.59e-06	2.14e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MAPK3—hematologic cancer	5.59e-06	2.14e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—SRC—hematologic cancer	5.57e-06	2.13e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—KRAS—hematologic cancer	5.56e-06	2.13e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—KRAS—hematologic cancer	5.56e-06	2.13e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	5.55e-06	2.12e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—PTEN—hematologic cancer	5.54e-06	2.12e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—HRAS—hematologic cancer	5.52e-06	2.11e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—VEGFA—hematologic cancer	5.52e-06	2.11e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—PIK3CA—hematologic cancer	5.49e-06	2.1e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—HRAS—hematologic cancer	5.48e-06	2.1e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CDKN1A—hematologic cancer	5.46e-06	2.09e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—STAT3—hematologic cancer	5.46e-06	2.09e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PTEN—hematologic cancer	5.45e-06	2.09e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—NRAS—hematologic cancer	5.45e-06	2.08e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MYC—hematologic cancer	5.43e-06	2.08e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—VEGFA—hematologic cancer	5.43e-06	2.08e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MAPK8—hematologic cancer	5.42e-06	2.07e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—TGFB1—hematologic cancer	5.42e-06	2.07e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—CREBBP—hematologic cancer	5.41e-06	2.07e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—HRAS—hematologic cancer	5.41e-06	2.07e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—AKT1—hematologic cancer	5.4e-06	2.07e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	5.39e-06	2.06e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CDKN1B—hematologic cancer	5.39e-06	2.06e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—STAT3—hematologic cancer	5.37e-06	2.06e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MAPK3—hematologic cancer	5.36e-06	2.05e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—NRAS—hematologic cancer	5.36e-06	2.05e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	5.33e-06	2.04e-05	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—AKT1—hematologic cancer	5.33e-06	2.04e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	5.32e-06	2.04e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—TP53—hematologic cancer	5.31e-06	2.03e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—ABCB1—hematologic cancer	5.29e-06	2.03e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—IL6—hematologic cancer	5.28e-06	2.02e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—EP300—hematologic cancer	5.28e-06	2.02e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CASP3—hematologic cancer	5.28e-06	2.02e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IL2—hematologic cancer	5.27e-06	2.02e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—IL6—hematologic cancer	5.24e-06	2.01e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MYC—hematologic cancer	5.24e-06	2.01e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	5.23e-06	2e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MAPK3—hematologic cancer	5.22e-06	2e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MYC—hematologic cancer	5.22e-06	2e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	5.2e-06	1.99e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—EP300—hematologic cancer	5.2e-06	1.99e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—IL6—hematologic cancer	5.17e-06	1.98e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—PIK3CA—hematologic cancer	5.15e-06	1.97e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—GSTM1—hematologic cancer	5.14e-06	1.97e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—NCOR1—hematologic cancer	5.14e-06	1.97e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	5.14e-06	1.97e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—SRC—hematologic cancer	5.14e-06	1.97e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MAPK3—hematologic cancer	5.13e-06	1.96e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	5.13e-06	1.96e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—JUN—hematologic cancer	5.13e-06	1.96e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—PIK3CA—hematologic cancer	5.11e-06	1.95e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—PIK3CA—hematologic cancer	5.11e-06	1.95e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—HRAS—hematologic cancer	5.08e-06	1.94e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MYC—hematologic cancer	5.07e-06	1.94e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—ALB—hematologic cancer	5.07e-06	1.94e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—TGFB1—hematologic cancer	5.06e-06	1.94e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—SRC—hematologic cancer	5.06e-06	1.93e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—KRAS—hematologic cancer	5.02e-06	1.92e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	5e-06	1.91e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MYC—hematologic cancer	4.99e-06	1.91e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—TGFB1—hematologic cancer	4.98e-06	1.91e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	4.97e-06	1.9e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	4.96e-06	1.9e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—STAT3—hematologic cancer	4.95e-06	1.9e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—NRAS—hematologic cancer	4.94e-06	1.89e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—TP53—hematologic cancer	4.94e-06	1.89e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—TP53—hematologic cancer	4.94e-06	1.89e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	4.92e-06	1.88e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—STAT3—hematologic cancer	4.88e-06	1.87e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—AKT1—hematologic cancer	4.88e-06	1.87e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—NRAS—hematologic cancer	4.86e-06	1.86e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—IL6—hematologic cancer	4.86e-06	1.86e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	4.85e-06	1.86e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	4.85e-06	1.85e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—KRAS—hematologic cancer	4.85e-06	1.85e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	4.84e-06	1.85e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—KRAS—hematologic cancer	4.82e-06	1.84e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—AKT1—hematologic cancer	4.77e-06	1.83e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	4.73e-06	1.81e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—EP300—hematologic cancer	4.73e-06	1.81e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—HRAS—hematologic cancer	4.73e-06	1.81e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—HRAS—hematologic cancer	4.73e-06	1.81e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—KRAS—hematologic cancer	4.69e-06	1.79e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	4.66e-06	1.78e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—KRAS—hematologic cancer	4.61e-06	1.77e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—PIK3CA—hematologic cancer	4.61e-06	1.76e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MYC—hematologic cancer	4.6e-06	1.76e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—SRC—hematologic cancer	4.6e-06	1.76e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	4.59e-06	1.76e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—MTHFR—hematologic cancer	4.54e-06	1.74e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MYC—hematologic cancer	4.53e-06	1.73e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—IL6—hematologic cancer	4.52e-06	1.73e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—IL6—hematologic cancer	4.52e-06	1.73e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	4.52e-06	1.73e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—AKT1—hematologic cancer	4.48e-06	1.72e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	4.48e-06	1.71e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	4.47e-06	1.71e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—TP53—hematologic cancer	4.46e-06	1.71e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	4.45e-06	1.7e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	4.44e-06	1.7e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	4.43e-06	1.69e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	4.42e-06	1.69e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—PIK3CA—hematologic cancer	4.31e-06	1.65e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—TP53—hematologic cancer	4.31e-06	1.65e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—TP53—hematologic cancer	4.28e-06	1.64e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—HRAS—hematologic cancer	4.27e-06	1.63e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—KRAS—hematologic cancer	4.25e-06	1.63e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—PIK3CA—hematologic cancer	4.24e-06	1.62e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	4.24e-06	1.62e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—AKT1—hematologic cancer	4.21e-06	1.61e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—KRAS—hematologic cancer	4.19e-06	1.6e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—PIK3CA—hematologic cancer	4.18e-06	1.6e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—AKT1—hematologic cancer	4.17e-06	1.6e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—AKT1—hematologic cancer	4.17e-06	1.6e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—TP53—hematologic cancer	4.17e-06	1.59e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MYC—hematologic cancer	4.12e-06	1.58e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—HRAS—hematologic cancer	4.12e-06	1.58e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	4.11e-06	1.57e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—TP53—hematologic cancer	4.1e-06	1.57e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—HRAS—hematologic cancer	4.1e-06	1.57e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—IL6—hematologic cancer	4.08e-06	1.56e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—HRAS—hematologic cancer	3.99e-06	1.53e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—IL6—hematologic cancer	3.94e-06	1.51e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—HRAS—hematologic cancer	3.92e-06	1.5e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—IL6—hematologic cancer	3.92e-06	1.5e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	3.91e-06	1.5e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PTEN—hematologic cancer	3.86e-06	1.48e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	3.85e-06	1.47e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.82e-06	1.46e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IL6—hematologic cancer	3.81e-06	1.46e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	3.81e-06	1.46e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—TP53—hematologic cancer	3.78e-06	1.45e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—AKT1—hematologic cancer	3.77e-06	1.44e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IL6—hematologic cancer	3.75e-06	1.44e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—TP53—hematologic cancer	3.72e-06	1.42e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—EP300—hematologic cancer	3.69e-06	1.41e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—AKT1—hematologic cancer	3.64e-06	1.39e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—AKT1—hematologic cancer	3.62e-06	1.38e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—HRAS—hematologic cancer	3.62e-06	1.38e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—HRAS—hematologic cancer	3.56e-06	1.36e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CREBBP—hematologic cancer	3.54e-06	1.35e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—AKT1—hematologic cancer	3.52e-06	1.35e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	3.5e-06	1.34e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—AKT1—hematologic cancer	3.46e-06	1.33e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IL6—hematologic cancer	3.46e-06	1.32e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—AKT1—hematologic cancer	3.42e-06	1.31e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IL6—hematologic cancer	3.41e-06	1.3e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—TP53—hematologic cancer	3.38e-06	1.3e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	3.35e-06	1.28e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—ALB—hematologic cancer	3.31e-06	1.27e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	3.24e-06	1.24e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—AKT1—hematologic cancer	3.19e-06	1.22e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	3.17e-06	1.21e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—AKT1—hematologic cancer	3.14e-06	1.2e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IL6—hematologic cancer	3.1e-06	1.19e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.92e-06	1.12e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	2.86e-06	1.09e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.73e-06	1.04e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PTEN—hematologic cancer	2.53e-06	9.67e-06	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—EP300—hematologic cancer	2.41e-06	9.22e-06	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—AKT1—hematologic cancer	2.23e-06	8.52e-06	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.78e-06	6.82e-06	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—AKT1—hematologic cancer	1.46e-06	5.57e-06	CbGpPWpGaD
